Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients

Seminars in Respiratory Infections

Volumn 17, Issue 2, 2002, Pages 113-120

  Jahagirdar, Balkrishna N ^a,b   Morrison, Vicki A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CYTOTOXIC AGENT; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; DISEASE COURSE; DRUG CHOICE; EARLY DIAGNOSIS; FUSARIUM; HEMATOLOGIC DISEASE; HUMAN; INFECTION RATE; INFECTION RISK; INFECTION SENSITIVITY; MALASSEZIA; MYCOSIS; NEUTROPENIA; PAECILOMYCES; PENICILLIUM; PRIORITY JOURNAL; REVIEW; SCEDOSPORIUM; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TRICHOSPORON; ZYGOMYCETES;

BONE MARROW TRANSPLANTATION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 0036081848     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2002.33446     Document Type: Review

References (68)

1. The emerging role of Fusarium infections in patients with cancer
2. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management
3. Disseminated infection with Fusarium in recipients of bone marrow transplants
4. Opportunistic fusarial infections in humans
5. Invasive Fusarium infections: A retrospective survey of 31 cases
6. Miscellaneous Fungi and Prototheca
7. Fungaemia due to Fusarium spp. in cancer patients
8. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
9. Emerging pathogens
10. Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century
11. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species
12. Successful treatment of disseminated Fusarium infection in an immunocompromised child
13. Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient
14. Breakthrough fungemia appearing during empiric therapy with amphotericin B
15. The new fungal opportunists are coming
16. Clinical patterns of Fusarium infections in immunocompromised patients
17. Agents of mucormycosis
18. Mucormycosis in hematologic malignancies: An emerging fungal infection
19. Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases
20. Mucormycosis in allogeneic bone marrow transplant recipients: Report of five cases and review of the role of iron overload in the pathogenesis
21. Mucormycosis in the BMT population
22. Mucormycosis after bone marrow transplantation: Report of four cases in thalassemia and review of the literature
23. Iron overload is a risk factor for zygomycosis
24. Pulmonary mucormycosis: Radiologic findings in 32 cases
25. Isolated cerebral mucormycosis in leukemia
26. Gastrointestinal mucormycosis complicated by arterio-enteric fistula in a patient with non-Hodgkin's lymphoma
27. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex
28. Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation
29. Successful treatment of invasive thoracopulmonary mucormycosis in a patient with acute lymphoblastic leukemia
30. Scedosporium inflatum: Clinical spectrum of a newly recognized pathogen
31. Clinical features of human infection with Scedosporium inflatum
32. Scedosporium inflatum infection in immunocompromised haematological patients
33. Disseminated infection and colonization by Scedosporium prolificans: A review of 18 cases, 1990-1999
34. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): Four fatal cases in leukemic patients
35. Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation
36. Fatal meningoencephalitis caused by Scedosporium inflatum (Scedosporium prolificans) in a child with lymphoblastic leukemia
37. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor
38. Amphotericin B responsive Scedosporium apiospermum infection in a patient with acute myeloid leukaemia
39. Scedosporium infection in immuno-compromised patients: Successful use of liposomal amphotericin B and itraconazole
40. Use of voriconazole in treatment of Scedosporium apiospermum infection: Case report
41. Texonomic position of deep-seated, mucosa associated, and superficial isolates of Trichosporon cutanum from trichosporinosis patients
42. Colonization and infection with Trichosporon species in the immunosuppressed host
43. Trichosporon beigelii fungemia in patients with acute leukemia: Report of three cases
44. Invasive Trichosporon cutaneum infection: An increasing problem in immunosuppressed patients
45. Trichosporon species infection in bone marrow transplanted patients
46. Malassezia fungemia in neonates and adults: Complication of hyperalimentation
47. The spectrum of Malassezia infections in the bone marrow transplant population
48. Pityrosporum folliculitis after bone marrow transplantation. Clinical observations in five patients
49. Systemic infections with Malassezia furfur in an adult receiving long term hyperalimentation therapy
50. Failure to eradicate Malassezia furfur broviac catheter infection with antifungal therapy
51. Alternaria: A sinonasal pathogen of immunocompromised hosts
52. Etiological role of Alternaria alternata in human esophageal cancer
53. Cutaneous microabscess formation from Alernaria alternata
54. Alternaria infection in a patient with acute lymphocytic leukemia
55. Cutaneous manifestations of Paecilomyces lilacinus infection induced by contaminated skin lotion in patients who are severely immunosuppressed
56. Endocarditis following cardiac surgery due to fungus Paecilomyces
57. Fungal endophthalmitis following intra-ocular lens implantation: A surgical epidemic
58. Paecilomyces lilacinus cellulitis in an immunocompromised patient
59. Paecilomyces sinusitis in an immunocompromised adult patient: Case report and review
60. Dermatologic manifestations of infections in immunocompromised patients
61. Paecilomyces varioti pneumonia complicating hairy cell leukaemia
62. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient
63. Paecilomyces varioti fungemia in a bone marrow transplant patient
64. Paecilomyces lilacinus catheter-related fungemia in an immunocompromised pediatric patient
65. Disseminated Penicillium merneffei infection in Southeast Asia
66. Penicillium brevicompactum as the cause of a necrotic lung ball in an allogeneic bone marrow transplant recipient
67. The spectrum of non-Candida fungal infections following bone marrow transplantation
68. Amphotericin B and itraconazole for treatment of disseminated Penicillium merneffei in human immunodeficiency virusinfected patients